5-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-1H-1,2,3-benzotriazole-6-carboxamide hydrochloride, 95+%, 250mg

Ethyl 2,4-dichlorobenzoylformate, 97.0%, 25g

Boîtes carrées ROTILABO®, 2000 ml, 1 Pièce

2-(3-methoxyphenyl)-6-methylquinoline-4-carboxylic acid, 95.0%, 1g

5,10,15,20-Tetrakis(4-methoxyphenyl)porphyrin>97.0%(HPLC)(T)100mg

2-Hydroxy-N,N,N-trimethylethan-1-aminium (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoate, 98.0%, 50mg

1-(4-FLUORO-2-METHYLPHENYL)BUTAN-1-AMINE, 95.0%, 250mg

(R)-3,3'-Bis(3,5-bis(trifluoromethyl)phenyl)-[1,1'-binaphthalene]-2,2'-diol, 98%, 1g

4-Chloromethyl-thiazol-2-ylamine hydrochloride, 95.0%, 25g

4-Bromo-1H-indole-7-carbonitrile, 95.0%, 5g

Methyl 3-hydroxy-1H-pyrrole-2-carboxylate, 95.0%, 5g

1-[1-(4-fluorophenyl)cyclopropyl]methanamine hydrochloride, 98%, 500mg

3-Bromo-1-methylpyridin-4(1H)-one, 95%, 25g